BioCentury
ARTICLE | Top Story

CMS wants HCV company input on Medicaid best price

November 6, 2015 3:27 AM UTC

CMS sent AbbVie Inc. (NYSE:ABBV), Merck & Co. Inc. (NYSE:MRK), Gilead Sciences Inc. (NASDAQ:GILD) and Johnson & Johnson (NYSE:JNJ).

The agency said it wants to learn about the challenges manufacturers face in offering Medicaid agencies value-based purchasing arrangements, including outcomes-based pricing models. ...